Bo Long
- Topics
- Peptidase Inhibition and Analysis (3 papers)Gastric Cancer Management and Outcomes (3 papers)CAR-T cell therapy research (2 papers)
- Cited by
- ImmunologyOncologyAquatic Science
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Bo Long
13 papers receiving 290 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 126
- Immunology 111
- Oncology 100
- Cancer Research 37
- Pulmonary and Respiratory Medicine 35
Countries citing papers authored by Bo Long
This map shows the geographic impact of Bo Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Long more than expected).
Fields of papers citing papers by Bo Long
This network shows the impact of papers produced by Bo Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Long. The network helps show where Bo Long may publish in the future.
Co-authorship network of co-authors of Bo Long
This figure shows the co-authorship network connecting the top 25 collaborators of Bo Long. A scholar is included among the top collaborators of Bo Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Long. Bo Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 24 | |
| 4 | 78 | |
| 5 | 10 | |
| 6 | 13 | |
| 7 | 27 | |
| 8 | 25 | |
| 9 | 21 | |
| 10 | 8 | |
| 11 | 3 | |
| 12 | 55 | |
| 13 | 26 |
About Bo Long
Bo Long is a scholar working on Gastroenterology, Oncology and Microbiology, having authored 13 papers that have together received 293 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Gastric Cancer Management and Outcomes (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (111 citations), Oncology (100 citations) and Aquatic Science (20 citations). Bo Long has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zeyuan Yu, Huinian Zhou, Wengui Shi, Xiangyan Jiang, Zuoyi Jiao, Long Qin, Qian Yang, Yi Geng, Kaiyu Wang and Erlong Wang. Their work appears in journals such as Journal of Clinical Oncology, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.